Miscommunication involving 'standard care'. Response to protocol review scenario: revise protocol form.

摘要

Dr. Herb Birnbaum, working for a small biotechnology company, was studying the expression of the gene Brcal in mice that had malignant ovarian tumors, mammary tumors or both tumors implanted subcutaneously. The goal of the study was to maintain the animals in good health as long as possible and to determine whether Brcal was overexpressed in animals that had both tumors, as compared with animals that had only one or the other. Birnbaum contracted with Great Eastern University for animal housing, care and procedural space. Birnbaum's own technicians carried out the experimental procedures. His protocol had been reviewed and approved by the Great Eastern IACUC.